頁籤選單縮合
題 名 | Mitomycin-C在翼狀贅片治療上的運用=The Application of Mitomycin C in the Treatment of Pterygium |
---|---|
作 者 | 鄭惠川; 汪正光; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷 期 | 37:1 1998.03[民87.03] |
頁 次 | 頁35-42 |
分類號 | 416.741 |
關鍵詞 | 翼狀贅片治療; Conjunctival autograft transplantation; Mitomycin C; Recurrent pterygium; Thio-tepa; |
語 文 | 中文(Chinese) |
中文摘要 | 即使已有相當多藥物或手術的治療方式被發表過,復發仍是翼狀贅片治療上最大 的隱憂。所以在使鞏膜裸露的簡單切除之外,不斷地有許多更有效的附加治療方式被發表過, Mitomycin C即是其中一種;本報告的目的即在比較Mitomycin C與其他附加治療的效果。對 於初次復發的翼狀贅片,我們比較了Mitomycin C與結膜瓣移植的效果,結果顯示術中單次使 用Mitomycin C與結膜瓣移植的術後復發率並不具統計上有意義的差異(P=0.09);而對於原發 性翼狀贅片,我們則比較了Mitomycin C與Thio-tepa的效果,結果顯示術中單次使用 Mitomycin C與Thio-tepa術後點眼的復發率具有統計上有意義的差異(P=0.02)。另一方面, 在本報告中所有使用Mitomycin C的病例皆未見嚴重的併發症。藉由這個研究結果,我們認為 對於復發性的翼狀贅片術中單次使用Mitomycin C與結膜瓣移植的效果並無差異;而對於原發 性翼狀贅片術中單次使用Mitomycin C則較Thio-tepa術後點眼有效。 |
英文摘要 | A number of adjunctive therapies have been employed to decrease the risk of recurrence after surgical removal of a pterygium. The intraoperative application of mitomycin C is one of these methods. This prospective, randomized study was carried out in two parts. The efficacy of mitomycin C was compared with that of conjunctival autograft in the management of recurrent pterygia, but no sifnificant difference (P=0.09) was found between them. While the efficacy of mitomycin C was compared with that of topical thio-tepa in the treatment of primary cases, the result revealed statistically significant difference (P=0.02). In addition, there is no serious complication after the application of mitomycin C. Therefore, we concluded that there was no difference in the efficacy between mitomycin C and conjuntival autograft in the treatment of recurrent pterygia. But on the other hand, the intraoperative application of mitomycin C was superior to topical thio-tepa as an adjunctive therapy in the surgical excision of primary pterygia for Chinese patients. |
本系統中英文摘要資訊取自各篇刊載內容。